SG11201601570QA - Site-specific nuclease single-cell assay targeting gene regulatory elements to silence gene expression - Google Patents

Site-specific nuclease single-cell assay targeting gene regulatory elements to silence gene expression

Info

Publication number
SG11201601570QA
SG11201601570QA SG11201601570QA SG11201601570QA SG11201601570QA SG 11201601570Q A SG11201601570Q A SG 11201601570QA SG 11201601570Q A SG11201601570Q A SG 11201601570QA SG 11201601570Q A SG11201601570Q A SG 11201601570QA SG 11201601570Q A SG11201601570Q A SG 11201601570QA
Authority
SG
Singapore
Prior art keywords
site
regulatory elements
cell assay
specific nuclease
gene expression
Prior art date
Application number
SG11201601570QA
Inventor
Stephanie Fanucchi
Youtaro Shibayama
Shaun Burd
Musa M Mhlanga
Original Assignee
Csir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csir filed Critical Csir
Publication of SG11201601570QA publication Critical patent/SG11201601570QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6841In situ hybridisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201601570QA 2013-09-04 2014-09-04 Site-specific nuclease single-cell assay targeting gene regulatory elements to silence gene expression SG11201601570QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA201306649 2013-09-04
PCT/IB2014/064259 WO2015033293A1 (en) 2013-09-04 2014-09-04 Site-specific nuclease single-cell assay targeting gene regulatory elements to silence gene expression

Publications (1)

Publication Number Publication Date
SG11201601570QA true SG11201601570QA (en) 2016-04-28

Family

ID=51626563

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201801782PA SG10201801782PA (en) 2013-09-04 2014-09-04 Site-specific nuclease single-cell assay targeting gene regulatory elements to silence gene expression
SG11201601570QA SG11201601570QA (en) 2013-09-04 2014-09-04 Site-specific nuclease single-cell assay targeting gene regulatory elements to silence gene expression

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201801782PA SG10201801782PA (en) 2013-09-04 2014-09-04 Site-specific nuclease single-cell assay targeting gene regulatory elements to silence gene expression

Country Status (8)

Country Link
US (2) US10167466B2 (en)
EP (2) EP3636750A1 (en)
JP (1) JP6535333B2 (en)
KR (1) KR20160048212A (en)
AU (1) AU2014316676B2 (en)
SG (2) SG10201801782PA (en)
WO (1) WO2015033293A1 (en)
ZA (1) ZA201601434B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10323236B2 (en) 2011-07-22 2019-06-18 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
WO2015070083A1 (en) 2013-11-07 2015-05-14 Editas Medicine,Inc. CRISPR-RELATED METHODS AND COMPOSITIONS WITH GOVERNING gRNAS
US9840699B2 (en) 2013-12-12 2017-12-12 President And Fellows Of Harvard College Methods for nucleic acid editing
EP3177718B1 (en) 2014-07-30 2022-03-16 President and Fellows of Harvard College Cas9 proteins including ligand-dependent inteins
CN107250148B (en) 2014-12-03 2021-04-16 安捷伦科技有限公司 Guide RNAs with chemical modifications
US20170349898A1 (en) * 2014-12-18 2017-12-07 Csir Immunomodulation by controlling elr+ proinflammatory chemokine levels with the long non-coding rna umlilo
KR102648489B1 (en) 2015-04-06 2024-03-15 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 Chemically modified guide RNA for CRISPR/CAS-mediated gene regulation
WO2017031370A1 (en) * 2015-08-18 2017-02-23 The Broad Institute, Inc. Methods and compositions for altering function and structure of chromatin loops and/or domains
EP3365356B1 (en) 2015-10-23 2023-06-28 President and Fellows of Harvard College Nucleobase editors and uses thereof
US10767175B2 (en) 2016-06-08 2020-09-08 Agilent Technologies, Inc. High specificity genome editing using chemically modified guide RNAs
GB2568182A (en) 2016-08-03 2019-05-08 Harvard College Adenosine nucleobase editors and uses thereof
AU2017308889B2 (en) 2016-08-09 2023-11-09 President And Fellows Of Harvard College Programmable Cas9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
WO2018049073A1 (en) 2016-09-07 2018-03-15 Flagship Pioneering, Inc. Methods and compositions for modulating gene expression
KR102622411B1 (en) 2016-10-14 2024-01-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 AAV delivery of nucleobase editor
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
DK3565891T3 (en) 2017-01-09 2023-07-24 Whitehead Inst Biomedical Res METHODS OF ALTERING GENE EXPRESSION BY DISRUPTING TRANSCRIPTION FACTOR MULTIMERS THAT STRUCTURE REGULATORY LOOPS
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
WO2018165629A1 (en) 2017-03-10 2018-09-13 President And Fellows Of Harvard College Cytosine to guanine base editor
EP3601562A1 (en) 2017-03-23 2020-02-05 President and Fellows of Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
CA3059208A1 (en) 2017-04-21 2018-10-25 The General Hospital Corporation Inducible, tunable, and multiplex human gene regulation using crispr-cpf1
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
US11732274B2 (en) 2017-07-28 2023-08-22 President And Fellows Of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
EP3676376A2 (en) 2017-08-30 2020-07-08 President and Fellows of Harvard College High efficiency base editors comprising gam
KR20200121782A (en) 2017-10-16 2020-10-26 더 브로드 인스티튜트, 인코퍼레이티드 Uses of adenosine base editor
KR101885560B1 (en) * 2017-11-23 2018-08-06 현진이너스주식회사 High strength cover for using composite material and filler
US11041155B2 (en) 2018-05-17 2021-06-22 The General Hospital Corporation CCCTC-binding factor variants
WO2020097564A1 (en) * 2018-11-09 2020-05-14 Arch Oncology, Inc. Biomarkers to improve efficacy of cancer immunotherapy
BR112021018606A2 (en) 2019-03-19 2021-11-23 Harvard College Methods and compositions for editing nucleotide sequences
CA3147643A1 (en) 2019-09-23 2021-04-01 Omega Therapeutics, Inc. Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (hnf4.alpha.) gene expression
DE112021002672T5 (en) 2020-05-08 2023-04-13 President And Fellows Of Harvard College METHODS AND COMPOSITIONS FOR EDIT BOTH STRANDS SIMULTANEOUSLY OF A DOUBLE STRANDED NUCLEOTIDE TARGET SEQUENCE
KR20240055811A (en) 2021-09-10 2024-04-29 애질런트 테크놀로지스, 인크. Guide RNA with chemical modifications for prime editing
CN114150043A (en) * 2021-11-24 2022-03-08 吉林农业大学 Detection method for inhibiting in vitro transcription activity of escherichia coli by bacterial transcription inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003218382B2 (en) * 2002-03-21 2007-12-13 Sangamo Therapeutics, Inc. Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
ES2808687T3 (en) * 2003-08-08 2021-03-01 Sangamo Therapeutics Inc Methods and compositions for directed cleavage and recombination
EP1526177A1 (en) * 2003-10-24 2005-04-27 Institut Curie Nucleic acids useful for triggering tumor cell lethality
WO2009042164A1 (en) * 2007-09-27 2009-04-02 Dow Agrosciences Llc Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genes
WO2010014857A2 (en) * 2008-07-30 2010-02-04 University Of Massachusetts Chromosome therapy
WO2011097036A1 (en) * 2010-02-08 2011-08-11 Sangamo Biosciences, Inc. Engineered cleavage half-domains
CN109554350B (en) * 2012-11-27 2022-09-23 儿童医疗中心有限公司 Targeting BCL11A distal regulatory elements for fetal hemoglobin re-induction

Also Published As

Publication number Publication date
US20160215280A1 (en) 2016-07-28
US20190112592A1 (en) 2019-04-18
KR20160048212A (en) 2016-05-03
WO2015033293A1 (en) 2015-03-12
AU2014316676A1 (en) 2016-03-17
SG10201801782PA (en) 2018-04-27
AU2014316676B2 (en) 2020-07-23
JP6535333B2 (en) 2019-06-26
EP3041931B1 (en) 2020-06-10
EP3041931A1 (en) 2016-07-13
US10167466B2 (en) 2019-01-01
ZA201601434B (en) 2020-07-29
EP3636750A1 (en) 2020-04-15
JP2016529907A (en) 2016-09-29

Similar Documents

Publication Publication Date Title
ZA201601434B (en) Site-specific nuclease single-cell assay targeting gene regulatory elements to silence gene expression
HK1214515A1 (en) Terminally modified rna (rna)
HK1207396A1 (en) Nuclease-mediated targeting with large targeting vectors
IL241426A0 (en) Nucleic acid amplification
IL241269A0 (en) Nucleic acid amplification
EP2839013A4 (en) Non-disruptive gene targeting
SG10201802883UA (en) Nucleic acid amplification
HK1207880A1 (en) Improved enzyme variants
HK1211988A1 (en) Multiphase nucleic acid amplification
GB201213117D0 (en) Transgene expression
EP2914731A4 (en) Reversible gene expression
EP2915815A4 (en) New modified nucleic acid
HK1232259A1 (en) Nucleic acid amplification
IL241273A0 (en) Nucleic acid amplification
GB201206455D0 (en) Gene expression
EP2814944A4 (en) Biomass yield genes
IL236116A0 (en) Controlled gene expression methods
EP2953647A4 (en) Positively charged polysaccharides for rna transfection
PL2978847T3 (en) Hammerhead ribozymes targeting mir-21
GB201309132D0 (en) Regulatable gene expression
IL240312A0 (en) Positively charged oplysaccharides for rna transfection
GB201307838D0 (en) Improved nucleic acid expressions
GB201306288D0 (en) Gene targeting in animals
GB201201397D0 (en) Gene targeting in animals
HU4193U (en) Laboratorial photo-bioreactor